Evaluation of tafazzin as candidate for dilated cardiomyopathy in Irish wolfhounds

Journal of Heredity

Volumn 98, Issue 5, 2007, Pages 506-509

  Philipp, Ute ^a   Broschk, Cornelia ^a   Vollmar, Andrea ^b   Distl, Ottmar ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CHILDREN S CANCER HOSPITAL   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; SIMAZINE;

CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXON; GENE SEGREGATION; GENE SEQUENCE; GENETIC LINKAGE; GENOME; GENOTYPE; INTRON; IRELAND; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; X CHROMOSOME;

3' UNTRANSLATED REGIONS; ANIMALS; CARDIOMYOPATHY, DILATED; CHROMOSOME MAPPING; DOG DISEASES; DOGS; GENOTYPE; INTRONS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; SPECIES SPECIFICITY;

CANIS FAMILIARIS;

EID: 34548434685     PISSN: 00221503     EISSN: 14657333     Source Type: Journal    
DOI: 10.1093/jhered/esm045     Document Type: Conference Paper

References (29)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. 2002. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 30:97-101.
2. Brownlie SE, Cobb MA. 1999. Observations on the development of congestive heart failure in Irish wolfhounds with dilated cardiomyopathy. J Small Anim Pract. 40:371-377.
3. D'Adamo P, Fassone L, Gedeon A, Janssen EA, Bione S, Bolhuis PA, Barth PG, Wilson M, Haan E, Orstavik KH, et al. 1997. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet. 61:862-867.
4. Distl O, Vollmar A, Broschk C, Hamann H, Fox PR. Forthcoming 2007. Complex segregation analysis of dilated cardiomyopathy (DCM) in Irish wolfhounds. Heredity. 10.1038/sj.hdy.680124.
5. Dukes-McEwan JI, Jackson J. 2002. The promises and problems of linkage analysis by using the current canine genome. Mamm Genome. 13:667-672
6. Guyon R, Lorentzen TD, Hitte C, Kim L, Cadieu E, Parker HG, Quignon P, Lowe JK, Renier C, Gelfenbeyn B, et al. 2003. A 1 Mb resolution radiation hybrid map of the canine genome. Proc Natl Acad Sci USA. 100:5296-5301.
7. Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T, Dreyer WJ, Messina J, Li H, Bowles NE, et al. 2001. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation. 103:1256-1263.
8. Kong A, Cox NJ. 1997. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet. 61:1179-1188.
9. Meurs KM. 1998. Insights into the hereditability of canine cardiomyopathy. Vet Clin North Am Small Anim Pract. 28:1449-1457.
10. Meurs KM. 2004. Boxer dog cardiomyopathy: an update. Vet Clin North Am Small Anim Pract. 34:1235-1244.
11. Meurs KM, Miller MW, Wright NA. 2001. Clinical features of dilated cardiomyopathy in Great Danes and results of a pedigree analysis: 17 cases (1999-2000). J Am Vet Med Assoc. 218:729-732.
12. Meurs KM, Spier AW, Miller MW, Lehmkuhl LB, Towbin JA. 1999. Familial ventricular arrhythmias in Boxers. J Vet Intern Med. 13:437-439.
13. Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F, Falaschi A, et al. 1996. A point mutation in the 5-prime splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet. 5:73-79.
14. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu M, G, Cianchetti C, Realdi G, Cao A, Melis MA. 1993. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. New Eng J Med. 329:921-925.
15. NCBI BLAST homepage. [Internet]. Available from:http://www.ncbi.nlm.nih. gov/blast/.
16. Neuwald AF. 1997. Barth syndrome may be due to an acyltransferase deficiency. Curr Biol. 7:R465-R466.
17. O'Grady M, Horne R. 1995. Outcome of 103 asymptomatic Doberman pinschers: incidence of dilated cardiomyopathy in a longitudinal study [abstract]. J Vet Int Med. 9:199.
18. O'Grady M, Horne R. 1998. The prevalence of dilated cardiomyopathy in Doberman pinschers: a 4.5 year follow up. J Vet Int Med. 5:199.
19. Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA. 1997. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 95:2434-2440.
20. Schatzberg SJ, Olby NJ, Steingold S, Keene B, Athins C, Meurs K, Solomon G, Goedegebuure SA, Wilton S, Sharp N. 1999. A polymerase chain reaction screening strategy for the promotor of the canine dystrophin gene. Am J Vet Res 60:1040-1046.
21. Spidey. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/spidey/.
22. Valianpour F, Wanders RJ, Overmars H, Vreken P, Van Gennip AH, Baas F, Plecko B, Santer R, Becker K, Barth PG. 2002. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, OMIM 302060): a study in cultured skin fibroblasts. J Pediatr. 141:729-733.
23. Vollmar A. 1999a. Echocardiographic measurements in the Irish wolfhound, reference values for the breed. J Am Anim Hosp Assoc. 35:271-277.
24. Vollmar A. 1999b. Use of echocardiography in the diagnosis of dilated cardiomyopathy in Irish wolfhounds. J Am Anim Hosp Assoc. 35:279-283.
25. Vollmar A. 2000. The prevalence of cardiomyopathy in the Irish wolfhound: a clinical study of 500 dogs. J Am Anim Hosp Assoc. 36:125-132.
26. 2 receptors in the normal and failing human heart. J Pharmacol Exp Ther. 284:323-336.
27. Whittemore AS, Halpern J. 1994. A class of tests for linkage using affected pedigree members. Biometrics. 50:118-127.
28. Xu Y, Kelley RI, Blanck TJ, Schlame M. 2003. Remodeling of cardiolipin by phospholipid transacylation. J Biol Chem. 278:51380-51385.
29. Yan X, Price RL, Nakayama M, Ito K, Schuldt AJ, Manning WJ, Sanbe A, Borg TK, Robbins J, Lorell BH. 2003. Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice. Am J Physiol Heart Circ Physiol. 285:H2179-H2187.